Susceptibility Testing of Fungi to Antifungal Drugs
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Susceptibility testing of fungi against antifungal drugs commonly used for therapy is a key component of the care of patients with invasive fungal infections. Antifungal susceptibility testing (AFST) has progressed in recent decades to finally become standardized and available as both Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methods and in commercial manual/automated phenotypic methods. In clinical practice, the Sensititre YeastOne and Etest methods are widely used for AFST, particularly for sterile site isolates of Candida. Nevertheless, AFST is moving toward new phenotypic methods, such as matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), that are capable of providing rapid, and potentially more actionable, results for the treating clinician. Our objective is to summarize updated data on phenotypic methods for AFST of Candida and Aspergillus species and to assess their significance in view of opposing, but emerging, molecular genotypic methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Potential treatment of invasive C. glabrata infection based on mass spectrometry– antifungal susceptibility testing (MS-AFST) results. In a clinical context of prior echinocandin exposure, results of susceptibility or resistance to anidulafungin and/or fluconazole within 3 h or, in cases of isolates with FKS2 HS1 mutations, 6–12 h after testing may guide the appropriate administration of antifungal therapy [69].](https://figures.cochat.ai/paper-figures/fd76e521811c4664bee8bad9f57a9b83/susceptibility-testing-of-fungi-to-antifungal-drugs-figure-1.jpg)
![Figure 2 Potential screening of azole-resistant A. fumigatus isolates. Shown is a stepwise workflow that eliminates false-positive results (indicated by a red X) and can be helpful to build up local epidemiological data on the prevalence and phylogenetic linkage of resistant isolates. In this figure, true positives are derived from the growth of isolates on selective agar plates containing drug concentrations that range from 0.5 μg/mL for posaconazole (PSZ) to 1 to 4 μg/mL for itraconazole (ITZ) or voriconazole (VRZ). Then, isolates are identified at the species level by multilocus DNA sequencing [46] (got permission to use).](https://figures.cochat.ai/paper-figures/d240c50e04e54fbdb42cad175fb309aa/susceptibility-testing-of-fungi-to-antifungal-drugs-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings also suggest an opportunity for increased use of AFST because AFST results can be an important adjunct in clinical decision-making [30].”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 2×
“As for Candida and Aspergillus, the i fection-related mortality rates are still unacceptably hig , despite recent advances in prophylaxis, e rly diagnosis, and treatment of fungal diseases [1].”
BackgroundPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Seng, P., Drancourt, M., Gouriet, F., La Scola, B., Fournier, P., Rolain, J. M., & Raoult, D. (2009) · Clinical Infectious Diseases · doi:10.1086/600885 · Cited by 1,983 · cited 1×
“However, this has occurred quickly for bacteria [58] but not so quickly for fungi [59].”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationWorldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555 · cited 1×
“Invasive fungal infections, especially those caused by the species Candida and Aspergillus, continue to rise in frequency [1] and, alarmingly, are associated with antifungal resistance [2], which makes the management of patients with such infections particularly challenging [3,4].”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298 · cited 3×
“glabrata against azoles and echinocandins [5].”
BackgroundCornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 1×
“Echinocandins represent first-line treatment of invasive Candida infections [5,31,32].”
BackgroundThe global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Clark, A. E., Kaleta, E. J., Arora, A., & Wolk, D. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-12 · Cited by 941 · cited 1×
“In many European clinical microbiology laboratories such as ours, the advent of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has drastically altered the routine diagnostic workflow [55,56].”
Background
Cited by
Houšť, J., Spížek, J., & Havlíček, V. (2020) · Metabolites · doi:10.3390/metabo10030106 · Cited by 254
Azole resistance mechanisms in Aspergillus: update and recent advances
Pérez-Cantero, A., López-Fernández, L., Guarro, J., & Capilla, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.011 · Cited by 172
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy
Mercer, D. K., Torres, M. D. T., Duay, S. S., Lovie, E., Simpson, L., von Köckritz-Blickwede, M., de la Fuente-Nunez, C., O'Neil, D. A., & Angeles-Boza, A. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00326 · Cited by 132
“Antimicrobial susceptibility testing (AST) determines the concentration of an antimicrobial that inhibits microbial growth, for both microbicidal and microbiostatic agents (Brown et al., 2016; Sanguinetti and Posteraro, 2018; Humphries et al., 2019; van Belkum et al., 2019).”
BackgroundMethodNeofytos, D., García‐Vidal, C., Lamoth, F., Lichtenstern, C., Perrella, A., & Vehreschild, J. J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05958-3 · Cited by 69
“such as MALDI-TOF mass spectrometry assays [68], is of critical value for the treatment of such patients and”
Assress, H. A., Selvarajan, R., Nyoni, H. H., Mamba, B. B., & Msagati, T. A. M. (2021) · Reviews in Environmental Science and Bio/Technology · doi:10.1007/s11157-021-09594-w · Cited by 73
“…or yeasts, is comprised of two widely accepted standard methods, which are, the European Union Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standard Institute (CLSI), which both apply the broth macro/micro-dilution method (Sanguinetti and Posteraro 2018).”
MethodDiagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Shelton, J., Collins, R., Uzzell, C. B., Alghamdi, A., Dyer, P. S., Singer, A. C., & Fisher, M. C. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.02061-21 · Cited by 64
Solid lipid nanoparticles, an effective carrier for classical antifungal drugs
Almawash, S. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.05.011 · Cited by 62
“AmB has a promising fungicidal activity for the treatment(s) of infections caused by Candida sp , Aspergillus sp. and Aspergillus fla-vus (Sanguinetti and Posteraro, 2018, Houštˇ et al., 2020).”
Basseri, H., Bakhtiyari, R., Hashemi, S. J., Baniardelani, M., Shahraki, H., & Hosainpour, L. (2019) · Journal of Medical Entomology · doi:10.1093/jme/tjz082 · Cited by 47
Azole antifungal resistance in fungal isolates from wastewater treatment plant effluents
Assress, H. A., Selvarajan, R., Nyoni, H. H., Ogola, H. J. O., Mamba, B. B., & Msagati, T. A. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-10688-1 · Cited by 37
Knoll, M. A., Ulmer, H., & Lass‐Flörl, C. (2021) · Journal of Fungi · doi:10.3390/jof7010063 · Cited by 33
Invasive Candidiasis: Epidemiology and Risk Factors
Cortés, J. A., & Corrales, I. F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81813 · Cited by 34
Mello, E., Posteraro, B., Vella, A., Carolis, E. D., Torelli, R., D’Inzeo, T., Verweij, P. E., & Sanguinetti, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00168-17 · Cited by 29
Self-citationNew approaches for antifungal susceptibility testing
Sanguinetti, M., & Posteraro, B. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.025 · Cited by 32
Self-citationGold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab512 · Cited by 20
“Our findings also suggest an opportunity for increased use of AFST because AFST results can be an important adjunct in clinical decision-making [30].”
BackgroundPhilips, S., Hoecke, F. V., Laere, E. D., Vervaeke, S., Smedt, R. D., Boelens, J., Geyter, D. D., Piérard, D., & Lagrou, K. (2021) · Journal of Fungi · doi:10.3390/jof7050356 · Cited by 21
Aydın, S., Derin, O., Şahin, M., Dinleyici, R., Yılmaz, M., Ceylan, B., Tosun, A. İ., Öztürk, R., & Mert, A. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.181 · Cited by 22
Lim, H. J., Shin, J. H., Kim, M., Yong, D., Byun, S. A., Choi, M. J., Lee, S. Y., Won, E. J., Kee, S., Kim, S. H., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00740-20 · Cited by 20
Corrêa-Junior, D., Parente, C. E. T., & Frasés, S. (2024) · Journal of Xenobiotics · doi:10.3390/jox14010007 · Cited by 21
“…this species This testing is recommended when there are concerns about resistance, or when the treatment of invasive infections is ineffective [55]. does not grow in in vitro culture There is a growing interest in culture-independent approaches, such While methods like broth microdilution…”
BackgroundMethodInfluentialElectroanalysis of Candida albicans biofilms: A suitable real-time tool for antifungal testing
Olaifa, K. W., Nikodinović‐Runić, J., Glišić, B. Đ., Boschetto, F., Marin, E., Segreto, F., & Marsili, E. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2021.138757 · Cited by 19
Essential Oils in Respiratory Mycosis: A Review
Zuzarte, M., & Salgueiro, L. (2022) · Molecules · doi:10.3390/molecules27134140 · Cited by 20
Fayyaz, H. A., EL-Massik, M. A. E., Bahey-El-Din, M., Abdel-Bary, A., Abdallah, O. Y., & Eltaher, H. M. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123663 · Cited by 16
Nguni, T. L., Abrantes, P. M. D. S., McArthur, C. P., Klaasen, J. A., & Fielding, B. C. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100503 · Cited by 18
Selvam, G. S., Thangaraju, D., Prabhu, A., & Mani, N. K. (2022) · ACS Omega · doi:10.1021/acsomega.2c02337 · Cited by 13
Brescini, L., Mazzanti, S., Orsetti, E., Morroni, G., Masucci, A., Pocognoli, A., & Barchiesi, F. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1783154 · Cited by 13
Melhem, M. D. S. C., Coelho, V. C., Fonseca, C. A., de Oliveira, L., Bonfietti, L. X., Szeszs, M. W., Magri, M. M. C., Dorneles, F. D. S., Taguchi, H., Moreira, D. V. D. S., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102161 · Cited by 11
Cortés, J. A., Valderrama-Ríos, M. C., Pietrobom, P. M. P., Silva, M., Díaz‐Brochero, C., Robles-Torres, R. R., Espinosa‐Almanza, C. J., Nócua-Báez, L. C., Nucci, M., Álvarez, C., et al. (2024) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2024.104495 · Cited by 10
Efficacy of Plant-Derived Fungicides at Inhibiting Batrachochytrium salamandrivorans Growth
Tompros, A., Wilber, M. Q., Fenton, A., Carter, E. D., & Gray, M. J. (2022) · Journal of Fungi · doi:10.3390/jof8101025 · Cited by 12
Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods
Vahedi‐Shahandashti, R., Hahn, L., Houbraken, J. A. M. P., & Lass‐Flörl, C. (2023) · Journal of Fungi · doi:10.3390/jof9030306 · Cited by 8
Special Issue: Treatments for Fungal Infections
Segal, E., & Elad, D. (2018) · Journal of Fungi · doi:10.3390/jof4040135 · Cited by 9
Antifungal Resistance Analysis of Environmental Isolates of Aspergillus in North India
Hoda, S., Agarwal, H., Ahluwalia, S. K., Vermani, M., & Vijayaraghavan, P. (2019) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.13.1.42 · Cited by 7
Xiao, C., Qiao, D., Xiong, L., Tian, W., Wang, D., Deng, S., & Guo, J. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s391069 · Cited by 7
“The partial internal transcribed spacer (ITS1–4) method combined with β-tubulin (BenA) gene sequences have been used for the identification of Aspergillus spp.(9,10) In addition, matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS) has been demonstrated to be a useful method for…”
MethodFluconazole Resistant Oral Candidiasis on HIV Patient - What Other Drug can We Choose? A Case Report
Murtiastutik, D., Prakoeswa, C. R. S., & Tantular, I. S. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.1.06 · Cited by 10
Antifungal Resistance in Animal Medicine: Current State and Future Challenges
Álvarez‐Pérez, S., García, M. E., Anega, B., & Blanco, J. L. (2021) · Fungal biology · doi:10.1007/978-3-030-69507-1_10 · Cited by 10
Chakrabarti, A., Oladele, R. O., Hermsen, E. D., de Figueiredo, M. L. N., Muñóz, P., & Johnson, M. D. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2479011 · Cited by 9
“Beyond that, for more precise and high-throughput pathogen identification and drug susceptibility determination, LMICs should stay informed about advances in molecular techniques (e.g. MALDI-ToF, mass spectroscopy, and flow cytometry), and strive to adopt them when feasible [93,98,99].”
Trovato, L., Calvo, M., Scalia, G., & Oliveri, S. M. (2023) · Microbiology Research · doi:10.3390/microbiolres14030072 · Cited by 6
Tonui, J., Mureithi, M., Jaoko, W. G., & Bii, C. C. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.227.26485 · Cited by 5
“Fungal pathogens have evolved substantially over the years exhibiting greater and increased resistance to the few existing antifungal agents [8].”
BackgroundDermatophytic Diseases: A Review of Tinea PedisPreprint
Gyamfi, J. A., Wezena, C. A., Saaka, R. A.-E., Sunyazi, S. S., Titigah, A. B., Abugri, D. A., & Abugri, J. (2021) · medRxiv · doi:10.1101/2021.06.28.21259664 · Cited by 5
EQUAL candida score can predict the prognosis of candidemia at a single center study
Asai, N., Ohashi, W., Shibata, Y., Sakanashi, D., Kato, H., Hagihara, M., & Mikamo, H. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102849 · Cited by 4
Asuquo, E. G., Udobi, C. E., & Eyibio, O. O. (2022) · Microbiology Research Journal International · doi:10.9734/mrji/2022/v32i81337 · Cited by 3
“The minimum inhibitory concentration (MIC) of the aqueous fraction against test dermatophytes was determined by the broth microdilution method as recommended by EUCAST [18] using a 96-well round-bottom plate.”
MethodAbdulla, N. Q. F., & Ismael, H. M. (2023) · Iraqi Journal of Science · doi:10.24996/ijs.2023.64.2.6 · Cited by 2
Onder, I. T., Alp, A., & Arıkan-Akdağlı, S. (2025) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2025.02678 · Cited by 1
Prognostic Impact of Nutritional Status in Patients with Candidemia
Asai, N., Ohashi, W., Shibata, Y., Sakanashi, D., Kato, H., Hagihara, M., & Mikamo, H. (2026) · Nutrients · doi:10.3390/nu18060936 · Cited by 1
Laboratory Diagnostics of Aspergillosis: Present State and Future Directions
Tomazin, R., & Matos, T. (2026) · Journal of Fungi · doi:10.3390/jof12050379 · Cited by 1
“In clinical practice, commercial, standardised methods informed by CLSI or EUCAST guidelines are generally preferred, whereas the reference CLSI and EUCAST broth microdilution procedures are mainly applied in research, surveillance, and antifungal development [52,53].”
Colombo, A. L., Magri, M. M. C., Carlesse, F. A. D. M. C., Falci, D. R., Garnica, M., Santos, D. W. D. C. L., Queiroz‐Telles, F., & Pasqualotto, A. C. (2026) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2026.105946 · Cited by 2
Júnior, C. J. D. S., Rodrigues, D. K. D. B., Dantas, R. D. S., & Souza, A. K. P. (2021) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2021.168684 · Cited by 1
Kesavachandran, U., Gnanasekar, R., & Chellappa, A. K. (2022) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2022.064 · Cited by 1
Nesvizhsky, Y. V., Afanasiev, S. S., Voropaev, A. D., Urban, Y. N., Suleimanova, M. E., Afanasiev, M. S., Budanova, E. V., & Voropaeva, E. A. (2023) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-407 · Cited by 1
Erfaninia, M., & Alizadeh, F. (2023) · شهباز. · doi:10.61186/mlj.17.1.27 · Cited by 1
Antifungal susceptibility testing, reporting and antifungal resistance: current status
Sığ, A. K. (2023) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2023.97957 · Cited by 3
“For Cryptococcus species, CLSI has determined genotype-Table Researchers especially stated that they did not encounter “very major error (susceptible result to resistant strain)” (5,7,15).”
BackgroundMethodInfluentialPoornachitra, P., Vadivel, J. K., Geetha, R. V., & Manoharan, S. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/489
TBHEB 2023-1 Vol 80 Full Printed Journal
ERCÖMERT, U. (2023) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2023.78545
Emerging Antifungal Resistance in Ocular Infections
de Oliveira, H. C., Tabuse, A. M., Höfling-Lima, A. L., & Rodrigues, A. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-19923-2_3
Souza, T. D. F., Ferreira, T. G., Polo, A. B., Lemos, A. S. D. O., Paula, P. D. L., Branca, M. T., Lazzarini, G., de Oliveira, D. A., Gamarano, L. R., Andrade, N. B., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108760
Constanta, P. D., Cicalău, G. I. P., Maghiar, L., Șipoș, L. R., Huniadi, A. C., Bodog, R. F., Bodog, T. M., Beiușanu, C., Bereteu-Costa, A.-D., Nagy, C., et al. (2026) · Journal of Fungi · doi:10.3390/jof12100722
“Standardization of inoculum, medium, incubation, and endpoint reading is what makes a MIC comparable between laboratories; it is not what makes it clinically predictive [30].”
Metadata
- Authors
- Sanguinetti, M., & Posteraro, B.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Sanguinetti, Maurizio
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2018-09-15
- Volume
- 4
- Issue
- 3
- Pages
- 110
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC6162686
- OpenAlex
- W2891394773
- Cited by
- 55
- References
- 87
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 9 · 2021: 12 · 2020: 6 · 2019: 5 · 2018: 1
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- antifungal susceptibility testing, invasive fungal infections, Candida, Aspergillus, MALDI-TOF mass spectrometry, Sensititre YeastOne, E-test, antifungal resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.